ArrayPatch

Executive Summary

ArrayPatch is an Irish biotech company pioneering a novel drug delivery platform based on its DerMap™ technology, a polymer-free, dissolvable microneedle patch. The company's initial focus is on onychomycosis (nail fungus), a condition affecting millions globally with limited treatment options due to poor drug penetration and long therapy durations. DerMap enables pain-free, targeted, and efficient transdermal delivery, potentially improving patient compliance and efficacy. The platform's versatility positions ArrayPatch to expand into other high-value dermatological indications and beyond, offering a significant value proposition over conventional oral and topical therapies.

Upcoming Catalysts (preview)

• Q2 2027Initiation of first-in-human clinical trial for onychomycosis60% success
• Q4 2026Strategic partnership or licensing deal for DerMap platform40% success
• Q3 2026Series A funding round closing70% success